AU2022901345A0 - Dermal formulation and use thereof - Google Patents

Dermal formulation and use thereof

Info

Publication number
AU2022901345A0
AU2022901345A0 AU2022901345A AU2022901345A AU2022901345A0 AU 2022901345 A0 AU2022901345 A0 AU 2022901345A0 AU 2022901345 A AU2022901345 A AU 2022901345A AU 2022901345 A AU2022901345 A AU 2022901345A AU 2022901345 A0 AU2022901345 A0 AU 2022901345A0
Authority
AU
Australia
Prior art keywords
dermal formulation
dermal
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022901345A
Inventor
Michael ANDREWS LUKE
Richard Buchta
Billie Roughan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marp Therapeutics Pty Ltd
Original Assignee
Marp Therapeutics Pty Ltd
Filing date
Publication date
Application filed by Marp Therapeutics Pty Ltd filed Critical Marp Therapeutics Pty Ltd
Publication of AU2022901345A0 publication Critical patent/AU2022901345A0/en
Pending legal-status Critical Current

Links

AU2022901345A 2022-05-19 Dermal formulation and use thereof Pending AU2022901345A0 (en)

Publications (1)

Publication Number Publication Date
AU2022901345A0 true AU2022901345A0 (en) 2022-06-02

Family

ID=

Similar Documents

Publication Publication Date Title
EP4095148A4 (en) Anti-trop-2 antidody-exatecan analog conjugate and medical use thereof
EP4183391A4 (en) Pharmaceutical composition and use thereof
EP4110066A4 (en) Formulations and uses thereof
EP4230618A4 (en) Benzylamine or benzyl alcohol derivative and use thereof
EP4114342A4 (en) Delivery of cosmetic agents, compositions and use thereof
EP4185265A4 (en) Diester cosmetic formulations and uses thereof
EP3954359A4 (en) Topical cosmetic composition and uses thereof
EP4130014A4 (en) Deuterated oxophenylarsine compound and use thereof
EP4119585A4 (en) Crosslinked hyaluronic acid and use thereof
EP4134068A4 (en) Bendamustine composition and use thereof
AU2023901591A0 (en) Dermal formulation and use thereof
AU2022901345A0 (en) Dermal formulation and use thereof
AU2024901516A0 (en) Dermal formulation and use thereof
EP4146247A4 (en) Pharmaceutical and cosmetic compositions comprising secretomes
EP4180040A4 (en) Pharmaceutical composition and application thereof
EP4115902A4 (en) Combined use of ctb006 and ponatinib
EP4164619A4 (en) Treatment methods and formulations
EP4144323A4 (en) Dental membrane and dental membrane set comprising same
EP4121026A4 (en) Persistant topical antimicrobial compositions and methods of using the same
EP4114362A4 (en) Cannabidiol nanodrug formulations and methods for use the same
TWI850037B (en) LincRNA-p21 AND USE THEREOF
AU2023903670A0 (en) Topical formulation and uses thereof
AU2022903420A0 (en) Topical formulation and uses thereof
AU2021903311A0 (en) Terpene-containing formulations and use thereof
EP4090159A4 (en) Pyrazolylpyrimidines and use thereof